Shares outstanding increased 56.8%
Shares outstanding changed +56.8% from the comparable as-filed period. The change ranks at the 86th percentile of 7 prior comparable changes.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Shares outstanding changed +56.8% from the comparable as-filed period. The change ranks at the 86th percentile of 7 prior comparable changes.
Working capital / assets changed +1871 basis points from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Current liabilities changed -26.5% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Operating income changed +26.1% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Revenue changed -100.0% from the comparable as-filed period.
Working capital changed +26.4% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
Research & development changed -35.4% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Free-cash-flow proxy changed +12.1% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.